Improved ReturnsMeeting and exceeding medium-term targets (10.1% return on sales; 28.8% ROCE) reflects a structural shift from volume to value. Higher capital efficiency and sustained operating returns support durable profitability, better reinvestment decisions and resilience across product cycles over the next 2–6 months.
Stronger Cash GenerationMaterial FCF growth (148.91%), positive operating cash generation (£3.9m) and reduced net debt to £24.5m improve liquidity and reduce leverage risk. This durable cash profile enhances the firm's ability to fund targeted capex, support working capital, and withstand industry cyclicality without relying on external financing.
Strategic Market FocusA clear pivot into regulated, higher-growth markets (IVD, drug delivery, aerospace) and exit of low-margin, capital-intensive activities creates durable structural tailwinds. These sectors offer multi-year programs, higher entry barriers and recurring revenue potential, improving margin sustainability and customer stickiness.